# Detection of AD Biomarkers in Tear Fluid

> **NCT04620902** · — · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 69 (actual)

## Conditions studied

- Cognitive Impairment

## Interventions

- **OTHER:** Tear sampling

## Key facts

- **NCT ID:** NCT04620902
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2020-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04620902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04620902, "Detection of AD Biomarkers in Tear Fluid". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04620902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*